Literature DB >> 26319991

Lipid accumulation product and metabolic syndrome: a population-based study in northern Iran, Amol.

N Motamed1, S Razmjou2,3, G Hemmasi3, M Maadi3, F Zamani4.   

Abstract

PURPOSE: Lipid accumulation product (LAP) demonstrated a strong predictive accuracy for metabolic syndrome (MetS) in previous studies. This study was conducted to determine the predictive performance of LAP compared to obesity indexes. Moreover, the optimal cutoff point of LAP based on the study population waist circumference threshold was estimated in both men and women.
METHODS: 5797 subjects with an average age of 44.77 ± 16.77 years for men and 43.78 ± 15.43 years for women were included in the present study. The ROC analysis was performed to assess the predictive accuracy of LAP in the diagnosis of MetS. The optimal cutoff point of LAP was determined according to maximal Youden index in both men and women.
RESULTS: The optimal cutoff points determined for LAP were 49.71 (sensitivity = 85.2 %, specificity = 82.3 %) for women and 39.89 (sensitivity = 86 %, specificity = 79.6 %) for men. Based on the assigned cutoff points, the prevalence of high LAP was obtained 44.1 % in men and 45.1 % in women. LAP also showed a significantly higher predictive performance for MetS compared to obesity measures and also TG.
CONCLUSION: LAP has a strong and reliable diagnostic accuracy for MetS in Iranian population in the north of Iran. LAP showed a better predictability than other obesity indexes assessed in the present study.

Entities:  

Keywords:  Cutoff point; Lipid accumulation product; Metabolic syndrome

Mesh:

Year:  2015        PMID: 26319991     DOI: 10.1007/s40618-015-0369-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese.

Authors:  F Wang; S Wu; Y Song; X Tang; R Marshall; M Liang; Y Wu; X Qin; D Chen; Y Hu
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-02-01       Impact factor: 4.222

2.  Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires.

Authors:  Mariana L Tellechea; Florencia Aranguren; María T Martínez-Larrad; Manuel Serrano-Ríos; Mariano J Taverna; Gustavo D Frechtel
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 19.112

Review 3.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

4.  Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease.

Authors:  Ji Eun Yun; Soyoung Won; Jidong Sung; Sun Ha Jee
Journal:  Circ J       Date:  2012-07-12       Impact factor: 2.993

5.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

6.  Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.

Authors:  S Xiang; F Hua; L Chen; Y Tang; X Jiang; Z Liu
Journal:  Exp Clin Endocrinol Diabetes       Date:  2013-02-20       Impact factor: 2.949

7.  Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study.

Authors:  Mohammadreza Bozorgmanesh; Farzad Hadaegh; Fereidoun Azizi
Journal:  Lipids Health Dis       Date:  2010-05-10       Impact factor: 3.876

8.  Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.

Authors:  Hiram Beltrán-Sánchez; Michael O Harhay; Meera M Harhay; Sean McElligott
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

9.  The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison.

Authors:  Henry S Kahn
Journal:  BMC Cardiovasc Disord       Date:  2005-09-08       Impact factor: 2.298

10.  Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over.

Authors:  Jui-Kun Chiang; Malcolm Koo
Journal:  BMC Cardiovasc Disord       Date:  2012-09-24       Impact factor: 2.298

View more
  21 in total

1.  Comparison of anthro-metabolic indicators for predicting the risk of metabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program.

Authors:  Neda Rabiei; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Mehdi Sadeghian; Saba Maleki Birjandi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-28

2.  Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study.

Authors:  S Popa; M Moţa; A Popa; E Moţa; C Serafinceanu; C Guja; D Catrinoiu; N Hâncu; R Lichiardopol; C Bala; A Popa; G Roman; G Radulian; R Timar; B Mihai
Journal:  J Endocrinol Invest       Date:  2016-04-28       Impact factor: 4.256

3.  Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease.

Authors:  Yuan-Lung Cheng; Yuan-Jen Wang; Keng-Hsin Lan; Teh-Ia Huo; Yi-Hsiang Huang; Chien-Wei Su; Wei-Yao Hsieh; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu; Shou-Dong Lee
Journal:  Gastroenterol Res Pract       Date:  2017-01-17       Impact factor: 2.260

4.  Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.

Authors:  Haijiang Dai; Weijun Wang; Ruifang Chen; Zhiheng Chen; Yao Lu; Hong Yuan
Journal:  Nutr Metab (Lond)       Date:  2017-08-01       Impact factor: 4.169

5.  Visceral Adiposity and Anthropometric Indicators as Screening Tools of Metabolic Syndrome among Low Income Rural Adults in Xinjiang.

Authors:  Shu-Xia Guo; Xiang-Hui Zhang; Jing-Yu Zhang; Jia He; Yi-Zhong Yan; Jiao-Long Ma; Ru-Lin Ma; Heng Guo; La-Ti Mu; Shu-Gang Li; Qiang Niu; Dong-Sheng Rui; Mei Zhang; Jia-Ming Liu; Kui Wang; Shang-Zhi Xu; Xiang Gao; Yu-Song Ding
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

6.  The effect of lipid accumulation product and its interaction with other factors on hypertension risk in Chinese Han population: A cross-sectional study.

Authors:  Jian Song; Yingying Zhao; Sumei Nie; Xue Chen; Xuesen Wu; Jing Mi
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

7.  Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese.

Authors:  Rui Li; Qi Li; Min Cui; Zegang Yin; Ling Li; Tingting Zhong; Yingchao Huo; Peng Xie
Journal:  J Diabetes Investig       Date:  2017-08-03       Impact factor: 4.232

8.  Comparison of Anthropometric and Atherogenic Indices as Screening Tools of Metabolic Syndrome in the Kazakh Adult Population in Xinjiang.

Authors:  Xiang-Hui Zhang; Mei Zhang; Jia He; Yi-Zhong Yan; Jiao-Long Ma; Kui Wang; Ru-Lin Ma; Heng Guo; La-Ti Mu; Yu-Song Ding; Jing-Yu Zhang; Jia-Ming Liu; Shu-Gang Li; Qiang Niu; Dong-Sheng Rui; Shu-Xia Guo
Journal:  Int J Environ Res Public Health       Date:  2016-04-16       Impact factor: 3.390

9.  Visceral adiposity and renal function: an observational study from SPECT-China.

Authors:  Kun Zhang; Qin Li; Yi Chen; Ningjian Wang; Yingli Lu
Journal:  Lipids Health Dis       Date:  2017-10-27       Impact factor: 3.876

10.  Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes.

Authors:  Chun-Ming Ma; Na Lu; Rui Wang; Xiao-Li Liu; Qiang Lu; Fu-Zai Yin
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.